Accelerating Evidence-based Action for Every Family Everywhere LAUNCH: WHO’s Full Value of Vaccines Assessment Report

Wednesday 3rd November from 1.30 pm (free to attend virtually online)
, Time Zone London, UK (GMT)

Hosted by The London School of Hygiene & Tropical Medicine

Worldwide over 20 million pregnant women are estimated to be affected by Group B Streptococcal infection. To date, most focus has been on infections in children, yet there are many additional consequences for women themselves, including stillbirths, preterm birth and long-term impacts for affected survivors. The WHO-led Value Case Proposition includes years of work by many teams from all over the world on new data, analysis regarding long-term health and economic consequences of GBS disease, and estimated costs/benefits of vaccination or other prevention approaches. The report findings will be relevant for families, policymakers, clinicians, scientists, & industry. There will be a particular spotlight on meningitis and this Report is linked to the WHO Global Roadmap to Defeat Meningitis by 2030.

This event will be live-streamed here:

You can also join the webinar here:

There is no password to join the link above on Wednesday 3rd November at 13.30 pm (GMT). (You will not be able to join the webinar link before the 3rd of November).

Full agenda below.

Time WHO Webstream
1:30 pm
1:35 pm

Launch of WHO Full Value of Vaccines Assessment Report

Dr Tedros Adhanom Ghebreyesus - Director-General of the World Health Organization
1:40 pm
1:50 pm
2:00 pm

GBS burden through lifecycle & around the world (talk)

With Prof Joy Lawn, Director of the MARCH Centre, London School of Hygiene and Tropical Medicine, Film - Every Family: Acting on Group B Strep
2:20 pm

The Economic Case for a GBS Vaccine (talk)

Prof Mark Jit, London School of Hygiene and Tropical Medicine
2:25 pm

Q&A from audience

Dr Philipp Lambach (WHO), Prof Joy Lawn, (LSHTM), Prof Mark Jit (LSHTM)
2:40 pm
2:50 pm
3:00 pm


3:30 pm

PLENARY 2 – Implications of the evidence

Welcome back with Dr Kim Eva Dickson (UNICEF)
3:35 pm

Keynote: Vaccines & equity: the value case for GBS maternal vaccines

Dr Kate O’Brien, Director of the Department of Immunization, Vaccines and Biological (WHO)
4:05 pm

Panel Discussion

Dr Marta Tufet, Head of Policy (GAVI), Dr Martina Baye (Government of Cameroon), Dr Annaliese Anderson (Pfizer), Dr Anisur Rahman Siddique (UNICEF), Dr Ajoke Sobanjo – Ter Meulen (Bill & Melinda Gates Foundation)
4:40 pm

Closing comments from launch convenors

Dr Marie-Pierre Preziosi (WHO), Vinny Smith (CEO of Meningitis Research Foundation), Prof Beate Kampmann, Director of The Vaccine Centre at the London School of Hygiene and Tropical Medicine
4:55 pm

Close by Chair

Implications for action from launch - call to action - where to get more info...
5:00 pm

Close of Day